Apricus, FDA start PrevOnco SPA Phase III study discussion
PrevOnco is Apricus’ proprietary treatment for hepatocellular carcinoma (liver cancer). It contains lansoprazole, a commonly marketed anti-ulcer compound which shows strong anti-cancer activity in mice bearing human liver
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.